These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Behavior of quizalofop-p and its commercial products in water by liquid chromatography coupled to high resolution mass spectrometry.
    Author: López-Ruiz R, Romero-González R, Martínez Vidal JL, Garrido Frenich A.
    Journal: Ecotoxicol Environ Saf; 2018 Aug 15; 157():285-291. PubMed ID: 29627412.
    Abstract:
    A degradation study of quizalofop-p and its commercial products (quizalofop-p-ethyl, quizalofop-p-tefuryl and propaquizafop) in water samples has been performed using ultra high-performance liquid chromatography coupled to Orbitrap mass spectrometry (UHPLC-Orbitrap-MS). CHHQ (dihydroxychloroquinoxalin), CHQ (6-chloroquinoxalin-2-ol) and PPA ((R)-2-(4-hydroxyphenoxy)propionicacid) were the main metabolites of this active substance (quizalofop-p) in water. The degradation of the parent compound has been monitored in distilled water. Several commercial products (Panarex®, Master-D® and Dixon®) were used to evaluate the degradation of the target compounds into their metabolites. The concentration of the main active substances (quizalofop-p-tefuryl, quizalofop-p-ethyl and propaquizafop) decreased during the degradation studies, whereas the concentration of quizalofop-p increased. DT50 of the main active substances ranged from 10 days to 70 days for most of the analytes, so it can be concluded that compounds are medium-high persistent in this matrix. Metabolites, such as PPA, CHHQ and CHQ, were detected in water samples after 7 days of the application of the commercial products at concentrations higher than their limits of quantification (> 0.1 µg/L). CHQ was detected at 1400 µg/L after 75 days of the application of quizalofop-p-ethyl commercial product. CHHQ and CHQ were found at the highest concentrations at 7-45 days after the application of quizalofop-p-tefuryl, whereas PPA was detected at higher concentrations (up to 5.37 µg/L) in propaquizafop samples.
    [Abstract] [Full Text] [Related] [New Search]